Ticker

July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Inversiones, Weibo, Verizon, and AT&T, as ideal buys. Analyst targets project average net gains of 40.39% for the top ten GVAS stocks by July 2027, with risk profiles generally below market volatility. The dividend dogcatcher strategy favors stocks whose $1K dividend income exceeds share price, with 36 of 54 GVAS stocks…

Dividend stocks are regaining appeal as interest rates fall and market volatility rises, offering higher returns and lower risk over time. Top ten Attractive Low Price Dogs are forecasted to deliver 29.51%–66.09% net gains by June 2027, with average risk 49% below the market. All top ten yield Attractive Low Price Dogs are fairly priced, with dividends from $1K invested exceeding or matching share prices.

HAYWARD, Calif.--(BUSINESS WIRE)--Applied Biomics launches Antigen Affinity Purified HCP Antibody delivering 95% HCP coverage for ELISA, WB and LC-MS workflows.

That operating business generates roughly $450M in annual free cash flow off 562M monthly active users, at a 2.26x EV/FCF multiple. Weibo trades at a $1.80B market cap while holding $2.34B in net balance sheet value (cash, investments, minus debt), meaning the market is effectively giving away the entire operating business. The discount exists due to China risk, a controlling shareholder (SINA) that prefers…

On Sunday, a team of nine researchers at Sina Weibo — the Chinese social media giant better known for its microblogging platform than for cutting-edge artificial intelligence — quietly posted a 14-page technical report to arXiv that sent shockwaves through the AI research community. Their claim: a language model with just 3 billion parameters can match or exceed the reasoning performance of flagship systems from…